Medullary thyroid carcinoma (MTC) with an encapsulated tumor may correlate with the absence of nodal metastases and a better prognosis for patients, according to a study published in Frontiers in Endocrinology. The better prognosis was independent of RET or RAS gene mutational status.

A total of 15.9% (95% CI, 5.1%-26.7%) of tumors in the study were found to be encapsulated. None of these encapsulated MTC tumors (E-MTCs) were associated with distant or nodal metastases and the 7 patients with E-MTCs all achieved both structural and biochemical remission after resection surgery.

Read more about MTC prognosis.


Continue Reading

When compared to nonencapsulated MTC tumors (NE-MTCs), E-MTCs did not show multifocality, extrathyroidal extension, or vascular invasion (P =.004).

“The current research . . . provides support for the idea that tumor encapsulation may represent a valid tissue biomarker of node-negative MTC, even in the setting of focal full-thickness capsular invasion, and thus be predictive of a better prognosis, similar to what is well established in follicular-derived thyroid carcinomas,” the authors summarized.

There was also no statistical difference in presurgical calcitonin (Ctn) levels between E-MTC and NE-MTC patients who were not cured after surgery (P =.0633). Presurgical Ctn levels in NE-MTC who were cured after surgery (n=23; 62.2%) were significantly lower than E-MTC (P =.036) and NE-MTC patients who were not cured (P <.0001).

While not having significantly different presurgical Ctn levels compared to noncured NE-MTCs, E-MTCs were generally larger, with a median size of 33 mm compared to 16 mm, respectively (P =.036). Noncured NE-MTCs were also significantly larger than cured NE-MTCs (P =.008).

“Primary tumor size was higher for E-MTCs than non-cured NE-MTCs, so neither serum Ctn nor tumor diameter were predictive of persistence of disease when tumor encapsulation was present,” the authors said.

A total of 44 MTC patients who underwent follow-up between January 2017 and January 2022 at a single clinical site were included in the study. The median age of thyroidectomy was 56 years. Preoperative Ctn levels were found to be correlated with the size of the tumors (P <.001) but not with the number of tumors (P =.109) among the full patient cohort.

Reference

Contarino A, Dolci A, Maggioni M, et al. Is encapsulated medullary thyroid carcinoma associated with a better prognosis? A case series and a review of the literature. Front Endocrinol. 2022;13. doi:10.3389/fendo.2022.866572